Semantix, Inc. (NASDAQ:STIX) Short Interest Up 312.5% in February

Semantix, Inc. (NASDAQ:STIX) was the target of a significant growth in short interest during the month of February. As of February 29th, there was short interest totalling 23,100 shares, a growth of 312.5% from the February 14th total of 5,600 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 24,500 shares, the short-interest ratio is currently 0.9 days.

Semantix Stock Performance

Shares of STIX traded down $0.01 during trading hours on Thursday, reaching $0.78. 11,814 shares of the company traded hands, compared to its average volume of 27,561. The stock’s fifty day moving average is $0.69 and its 200 day moving average is $1.01. The stock has a market cap of $61.70 million, a P/E ratio of -0.96 and a beta of -0.48. Semantix has a 1-year low of $0.52 and a 1-year high of $4.96.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Barclays PLC acquired a new position in shares of Semantix during the first quarter valued at about $109,000. Geode Capital Management LLC acquired a new position in shares of Semantix during the first quarter valued at about $164,000. Finally, Morgan Stanley raised its position in Semantix by 190.1% in the fourth quarter. Morgan Stanley now owns 98,935 shares of the company’s stock worth $87,000 after purchasing an additional 64,835 shares in the last quarter. Institutional investors and hedge funds own 0.86% of the company’s stock.

About Semantix

Semantix, Inc, together with its subsidiaries, provides end-to-end proprietary Software as a Service (SaaS) data platform in Latin America and the United States. The company offers SDP, a multi-cloud SaaS data platform that provides data integration, data operations, machine learning operations, data governance, data sharing, and data visualization for financial institutions; healthcare plans operators, health insurance brokers, hospitals, clinics, and imaging and diagnostics facilities; and retailers.